OB/GYN Clinical Alert – August 1, 2022
August 1, 2022
View Issues
-
Self-Assessment of Gestational Duration Among People Seeking Abortion
In a national sample of people seeking abortion, broadening screening questions beyond last menstrual period to self-assess gestational duration improves accuracy in determining eligibility for medication abortion using a 70-day threshold. In-person ultrasound may not be necessary.
-
Permanent Contraception: How Effective Is it, Really?
In this retrospective cohort study using Medicaid claims data from 2008-2014 in California, the rate of pregnancy was 4.74% after hysteroscopic sterilization among 5,906 women and 5.57% after laparoscopic sterilization among 23,965 women. These rates are higher than reported previously.
-
Breast Cancer Screening: Tomosynthesis Is Beneficial for High-Risk Patients
This cohort study examined rates of advanced breast cancer diagnosis among women screened with digital mammography and digital breast tomosynthesis (DBT). Women with extremely dense breasts and who were at high risk for breast cancer benefited from DBT, with a 53% lower risk of developing advanced cancer compared to those screened with digital mammography alone. No differences were seen for women at low to average risk.
-
Pregnancy Outcomes in Cancer Survivors
This study demonstrated that women with a prior history of chemotherapy exposure have a higher prevalence of adverse pregnancy outcomes compared to those without a previous history, with no differences in neonatal outcomes.
-
OB/GYN Clinical Alert Welcomes Michael Roche as Peer Reviewer
Michael Roche, MD, joins OB/GYN Clinical Alert as peer reviewer.